Co-Development. 4.1 MiniMed and Insulet agree to work in good faith and with a reasonable time frame to discuss and attempt to negotiate a co-development and distribution arrangement whereby Insulet would develop a version of a CGM augmented insulin pump using the Insulet OmniPod System and the MiniMed CGM.
Appears in 2 contracts
Sources: Settlement & Cross License Agreement (Insulet Corp), Settlement and Cross License Agreement (Insulet Corp)